申请人:Roifman Chaim
公开号:US20060058554A1
公开(公告)日:2006-03-16
There is described compounds of Formula I, and salts, solvates and hydrates thereof:
wherein: R
1
, R
2
and R
3
are each independently selected from OH, C
1-6
alkyl, OC
1-6
alkyl, OC(O)C
1-6
alkyl, C(O)OC
1-6
alkyl, NH
2
, NH-C
1-6
alkyl, N(C
1-6
alkyl)(C
1-6
alkyl), C(O)NHC
1-6
alkyl, C(O)N(C
1-6
alkyl)(C
1-6
alkyl), SH, SC
1-6
alkyl, NO
2
, CF
3
, OCF
3
and halogen; and Ar is an aromatic or heteroaromatic group chosen from benzene, naphthalene, quinoline, isoquinoline, indole, pyridine, pyrasine, pyrimidine, imidazole, furan and thiophene, unsubstituted or substituted with 1-4 substituents independently selected from OH, C
1-6
alkyl, C
1-6
alkoxy, C
1-3
alkylenedioxy, NH
2
, NH-C
1-6
alkyl, N(C
1-6
alkyl)(C
1-6
alkyl), SH, S-C
1-6
alkyl, NO
2
, CF
3
, OCF
3
and halogen. The compounds of Formula I are useful: in therapeutic methods and compositions for modulating cell proliferation, in diagnostic assays and as research tools.
描述了化合物I的结构,以及其盐、溶剂合物和水合物:其中:R1、R2和R3分别独立地选择自OH、C1-6烷基、OC1-6烷基、OC(O)C1-6烷基、C(O)OC1-6烷基、NH2、NH-C1-6烷基、N(C1-6烷基)(C1-6烷基)、C(O)NHC1-6烷基、C(O)N(C1-6烷基)(C1-6烷基)、SH、SC1-6烷基、NO2、CF3、OCF3和卤素;Ar是从苯、萘、喹啉、异喹啉、吲哚、吡啶、吡啉、嘧啶、咪唑、呋喃和噻吩中选择的芳香或杂环芳基,未取代或取代有1-4个取代基,独立地选择自OH、C1-6烷基、C1-6烷氧基、C1-3烷基二氧基、NH2、NH-C1-6烷基、N(C1-6烷基)(C1-6烷基)、SH、S-C1-6烷基、NO2、CF3、OCF3和卤素。化合物I的结构在治疗方法和组合物中用于调节细胞增殖,在诊断分析和研究工具中有用。